“There Has Never Been A Better Time To Have A Headache” from The New York Times
Read more here
Study Looks at Safety of CGRP’s in Relation to People With Raynaud Phenomenon from JAMA Network
Read more here
“Biohaven Eyes Mid-2021 for Migraine Prevention Drug Launch” from CNBC Money Report
“I hope that in six months or so from now that we will be the first oral CGRP with the indication for the prevention of migraine,” Biohaven Pharmaceutical CEO Vlad Coric told CNBC. “Patients deserve to know that they can also prevent their next...
